NEFL and systemic lupus erythematosus: A decline in NfL concentrations over time may indicate the impact of settlements on treatment regimens reducing overall SLE disease activity, in line with two studies demonstrating declines in NfL concentrations after initiating immunotherapy in patients with active NPLSE [22, 25].